MYRIAD GENETICS INC — Director's Dealing 2013

May 10, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2013-05-10

Reporting Person: DREISMANN HEINRICH (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-05-10	Common Stock	M	30000	$18.05	Acquired	30000	Direct
2013-05-10	Common Stock	S	30000	$31.1609	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-05-10	Non-Qualified Stock Option (right to buy)	$18.05	M	30000	Disposed	2020-06-10	Common Stock (30000)	Direct

Footnotes

F1: Options vest in full upon completion of one full year of service, generally on the earlier of the first anniversary of the date of grant or the date of the next annual meeting of stockholders.